« Previous
Next »
Archives of Medical Research
Volume 37, Issue 7
, Pages 860-865
, October 2006
5-Fluorouracil and Weekly Oxaliplatin Combined with Radiotherapy for Locally Advanced Rectal Cancer: Surgical Complications and Long-term Results
References
- . Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479–1482
- and the Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–646
- . Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med. 1985;312:1465–1472
- Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med. 1991;324:709–715
- . Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444–1450
- and the German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–1740
- . Refining multimodal therapy for rectal cancer. N Engl J Med. 2001;345:690–692
- Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol. 2000;18:2938–2947
- Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol. 2000;18:136–147
- . Oxaliplatin: in vitro evidence of its radiation sensitizing activity. Pre-clinical observations relevant to clinical trials. Int J Radiat Oncol Biol Phys. 1999;45(Suppl 1):253–254
- Addition of oxaliplatin to continuous fluorouracil l-folinic acid and concomitant radiotherapy in rectal cancer: the Lyon R97–03 phase I trial. J Clin Oncol. 2001;19:2433–2438
- Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3–T4 unresectable rectal cancer: a phase II IATTGI study. Int J Radiat Oncol Biol Phys. 2002;54:397–402
- Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0–04 Phase II Trial. J Clin Oncol. 2003;21:1119–1124
- A phase I–II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann Oncol. 2005;16:1140–1166
- . Rectal cancer: CT local staging with histopathological correlation. Abdom Imaging. 2001;26:134–138
- Common toxicity criteria: Version 2.0—An improved reference for grading the acute effects of cancer treatment: impact on radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:13–47
- . Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181:335–346
- . Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996–999
- AJCC American Joint Committee on Cancer. In: Fleming DI, Cooper SJ, Henson ED, Hutter VR, Kennedy JB, Murphy PG, et al. editor. AJCC Cancer Staging Manual. 5th ed.. Philadelphia: Lippincott-Raven; 1997;p. 83–90
- Prognostic factors in colorectal cancer. College of American Pathologists Consensus statement 1999. Arch Pathol Lab Med. 2000;124:979–994
- Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg. 1999;230:544–552
- . Surgical treatment of adenocarcinoma of the rectum. Ann Surg. 1998;227:800–811
- Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2002;20:817–825
- . Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg. 1994;81:1224–1226
- Factors associated with the occurrence of leaks in stapled rectal anastomoses: a review of 1,014 patients. J Am Coll Surg. 1997;185:105–113
- . Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol. 2003;21:3098–3104
- Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis Colon Rectum. 2004;47:1798–1807
PII: S0188-4409(06)00164-0
doi: 10.1016/j.arcmed.2006.04.008
© 2006 IMSS. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Archives of Medical Research
Volume 37, Issue 7
, Pages 860-865
, October 2006
